Cargando…
P1070: NAVITOCLAX MONOTHERAPY IN PATIENTS WITH MYELOFIBROSIS PREVIOUSLY TREATED WITH JAK-2 INHIBITORS: SAFETY AND TOLERABILITY
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431288/ http://dx.doi.org/10.1097/01.HS9.0000847148.78233.c8 |
| _version_ | 1784780013197852672 |
|---|---|
| author | Pullarkat, V. Cruz-Chacon, A. Gangatharan, S. Melnyk, A. Palumbo, G. A. Bellini, M. Tantravahi, S. K. Qin, Q. Potluri, J. Vachhani, P. |
| author_facet | Pullarkat, V. Cruz-Chacon, A. Gangatharan, S. Melnyk, A. Palumbo, G. A. Bellini, M. Tantravahi, S. K. Qin, Q. Potluri, J. Vachhani, P. |
| author_sort | Pullarkat, V. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431288 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94312882022-08-31 P1070: NAVITOCLAX MONOTHERAPY IN PATIENTS WITH MYELOFIBROSIS PREVIOUSLY TREATED WITH JAK-2 INHIBITORS: SAFETY AND TOLERABILITY Pullarkat, V. Cruz-Chacon, A. Gangatharan, S. Melnyk, A. Palumbo, G. A. Bellini, M. Tantravahi, S. K. Qin, Q. Potluri, J. Vachhani, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431288/ http://dx.doi.org/10.1097/01.HS9.0000847148.78233.c8 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Pullarkat, V. Cruz-Chacon, A. Gangatharan, S. Melnyk, A. Palumbo, G. A. Bellini, M. Tantravahi, S. K. Qin, Q. Potluri, J. Vachhani, P. P1070: NAVITOCLAX MONOTHERAPY IN PATIENTS WITH MYELOFIBROSIS PREVIOUSLY TREATED WITH JAK-2 INHIBITORS: SAFETY AND TOLERABILITY |
| title | P1070: NAVITOCLAX MONOTHERAPY IN PATIENTS WITH MYELOFIBROSIS PREVIOUSLY TREATED WITH JAK-2 INHIBITORS: SAFETY AND TOLERABILITY |
| title_full | P1070: NAVITOCLAX MONOTHERAPY IN PATIENTS WITH MYELOFIBROSIS PREVIOUSLY TREATED WITH JAK-2 INHIBITORS: SAFETY AND TOLERABILITY |
| title_fullStr | P1070: NAVITOCLAX MONOTHERAPY IN PATIENTS WITH MYELOFIBROSIS PREVIOUSLY TREATED WITH JAK-2 INHIBITORS: SAFETY AND TOLERABILITY |
| title_full_unstemmed | P1070: NAVITOCLAX MONOTHERAPY IN PATIENTS WITH MYELOFIBROSIS PREVIOUSLY TREATED WITH JAK-2 INHIBITORS: SAFETY AND TOLERABILITY |
| title_short | P1070: NAVITOCLAX MONOTHERAPY IN PATIENTS WITH MYELOFIBROSIS PREVIOUSLY TREATED WITH JAK-2 INHIBITORS: SAFETY AND TOLERABILITY |
| title_sort | p1070: navitoclax monotherapy in patients with myelofibrosis previously treated with jak-2 inhibitors: safety and tolerability |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431288/ http://dx.doi.org/10.1097/01.HS9.0000847148.78233.c8 |
| work_keys_str_mv | AT pullarkatv p1070navitoclaxmonotherapyinpatientswithmyelofibrosispreviouslytreatedwithjak2inhibitorssafetyandtolerability AT cruzchacona p1070navitoclaxmonotherapyinpatientswithmyelofibrosispreviouslytreatedwithjak2inhibitorssafetyandtolerability AT gangatharans p1070navitoclaxmonotherapyinpatientswithmyelofibrosispreviouslytreatedwithjak2inhibitorssafetyandtolerability AT melnyka p1070navitoclaxmonotherapyinpatientswithmyelofibrosispreviouslytreatedwithjak2inhibitorssafetyandtolerability AT palumboga p1070navitoclaxmonotherapyinpatientswithmyelofibrosispreviouslytreatedwithjak2inhibitorssafetyandtolerability AT bellinim p1070navitoclaxmonotherapyinpatientswithmyelofibrosispreviouslytreatedwithjak2inhibitorssafetyandtolerability AT tantravahisk p1070navitoclaxmonotherapyinpatientswithmyelofibrosispreviouslytreatedwithjak2inhibitorssafetyandtolerability AT qinq p1070navitoclaxmonotherapyinpatientswithmyelofibrosispreviouslytreatedwithjak2inhibitorssafetyandtolerability AT potlurij p1070navitoclaxmonotherapyinpatientswithmyelofibrosispreviouslytreatedwithjak2inhibitorssafetyandtolerability AT vachhanip p1070navitoclaxmonotherapyinpatientswithmyelofibrosispreviouslytreatedwithjak2inhibitorssafetyandtolerability |